Outset Medical Inc. (OM) Tops Q4 EPS by 5c, provides guidance

Outset Medical Inc. (NASDAQ: OM) reported Q4 EPS of ($0.59), $0.05 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $30.5 million versus the consensus estimate of $30.13 million.

GUIDANCE:

Outset Medical Inc. sees Q1 2024 revenue of $145-153 million, versus the consensus of $148.9 million.

For earnings history and earnings-related data on Outset Medical Inc. (OM) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• UBS Reiterates Buy Rating on Cheniere Energy (LNG)